K961249

Substantially Equivalent

ACCUSIGN MET/BIOSIGN MET

Applicant: Princeton BioMeditech Corp.
Product code: LAF
Advisory panel: Clinical Toxicology
Date received: 1996-04-01
Decision date: 1996-04-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.